Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Biocon Biopharmaceuticals expands product portfolio

June 30, 2004

Cyclacel claims new CDK inhibitors for cancer and viral infections

June 29, 2004

Positive interim results from phase I study of Davanat-1

June 29, 2004

Change of indications for phase II trials of KOS-862

June 29, 2004

XL-119 enters phase III trial in bile duct cancer

June 29, 2004

Target enrollment met in phase III study of Campath for B-CLL

June 29, 2004

IND accepted for phase II trials of Aplidin

June 29, 2004

Two series of MEK/c-Src kinase inhibitors claimed by AstraZeneca

June 29, 2004

New antiangiogenic agents in early development at Bayer

June 28, 2004

New phase II study of talabostat in CLL

June 28, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 12, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 12, 2026
Alzheimer’s, beyond the brain
BioWorld
Researchers at Daping Hospital in China have reported that liver-targeted delivery of the APOE3-Christchurch (APOE3Ch) variant, a rare protective form of...
New assay for drug discovery against chemo-induced peripheral neuropathy
BioWorld Science
A group led by researchers at Boston Children’s Hospital established a scalable and reproducible model of paclitaxel-induced axon degeneration and neurotoxicity...
First cruise ship hantavirus genome points to zoonotic spillover
BioWorld
The initial appraisal of the first complete genome sequence of a hantavirus isolated from a patient in Switzerland who was a passenger on the cruise ship MV...